Month: March 2026

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) — AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced the peer-reviewed publication of results from its ongoing four-part Phase 2a study (NCT05660642) evaluating BPL-003 (mebufotenin benzoate nasal spray) in patients with treatment-resistant depression (TRD). Published in the Journal of Psychopharmacology, the newly reported data come from Cohort 1 – a 12 week, open-label trial of a single 10 mg intranasal dose of BPL-003 in 12 patients with moderate-to-severe TRD who were not taking concomitant antidepressants. BPL-003 produced a mean Montgomery–Åsberg Depression Rating Scale (MADRS) total score reduction...

BROOMFIELD, Colo., March 17, 2026 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today that it will participate in the 38th Annual ROTH Conference, March 22-24, 2026, in Dana Point, CA. During the conference, CEO Brent Ness will engage in one-on-one meetings with institutional investors and analysts to discuss the company’s progress advancing Nociscan, the company’s proprietary MR spectroscopy platform designed to help physicians identify painful discs in patients suffering from chronic low back pain. “We look forward to engaging with the investment community at ROTH to share the progress...

TORONTO, March 17, 2026 (GLOBE NEWSWIRE) — Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company”) announces initial results from the Phase 1 13,000-metre exploration drill program at the Eau Claire Gold project, located in the Eeyou Istchee Territory in the James Bay Region of Northern Quebec. Phase 1 drilling was focussed on expanding resources along high-grade shoots and adding continuity to the existing resource outside of the preliminary economic assessment identified stopes. A total of 21 holes (approximately 12,700m) has been completed, with results received for only 5,550m. Complete assay results have been received from 11 holes as well as partial results from a 12th hole. Seven holes returned significant results which are highlighted in Table 1 and Figure 1. The key highlight was infill drill hole...

Curated assortments at today’s most influential online retail destinations bring Lulus’ signature occasionwear to more shoppers CHICO, Calif., March 17, 2026 (GLOBE NEWSWIRE) — Lulu’s Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) (NASDAQ: LVLU), a women’s clothing brand offering modern, feminine styles at accessible prices for every occasion, today announced continued momentum in its wholesale expansion with the launch of a dedicated Lulus Amazon Storefront and new online wholesale partnership with Victoria’s Secret. The announcement builds on Lulus’ recent expansion into all Nordstrom stores nationwide and reflects the brand’s next phase of growth: a wholesale strategy designed to increase reach, drive incremental revenue, and deepen relevance across some of today’s most influential online retail destinations....

FDA Substantive Review and Meeting Scheduled for Early Q2 SUNNYVALE, Calif., March 17, 2026 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the FDA has accepted its pre-submission package for the approval of its Helix Transendocardial Delivery Catheter (“Helix”) intended for intramyocardial therapeutic and diagnostic agent delivery.    BioCardia has had preliminary meetings with both FDA Center for Devices and Radiological Health (CDRH) and FDA Center for Biological Evaluation and Research (CBER) on this submission in recent weeks. CDRH is expected to lead the review in consultation with CBER. CDRH has acknowledged the CBER CardiAMP Cell Therapy Breakthrough Designation enabled by Helix. “FDA marketing...

MEXICO CITY, March 17, 2026 (GLOBE NEWSWIRE) — Grupo Aeroméxico, S.A.B. de C.V. (“Aeroméxico” or the “Company”) (BMV & NYSE: AERO) today announced that it has been informed by certain members of its Board of Directors (the “Board”) and its executive management team that, using their personal resources and acting individually, they have acquired common shares and American Depositary Shares (“ADSs”) of the Company in the open market in Mexico and the United States, as applicable, in an aggregate amount of 1,032,120, common shares, equivalent to 103,212 ADSs. The Company believes these stock purchases reflect the continued confidence of the Board and executive management in the Company’s long-term strategy, performance, results, business plan, and growth prospects. The acquisitions were made in full compliance with the Company’s...

STAFFORD, Texas, March 17, 2026 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided a preliminary update showing a continued reduction in the recurrence rate in the fully enrolled, 250 patient, open label non-HLA-A*02 arm of FLAMINGO-01.6 Months of Additional Patient Data Since Last Update Shows Recurrence Rate of

LOS ANGELES, March 17, 2026 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 17, 2026 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). There will be simultaneous and archived webcasts available at https://wsw.com/webcast/key40/rdnt/1686072 About RadNet, Inc.RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of owned and/or operated outpatient imaging centers. RadNet’s markets include Arizona,...

SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM), a leading provider of innovative and sustainable infrastructure solutions for transportation, energy security and smart city infrastructure, today announced approximately $1.7 million in smart cities infrastructure product orders within a single week at Beam Europe, surpassing the Company’s previous $1.0 million weekly sales order milestone announced on February 12, 2026. The strong sales performance reflects a significant increase in orders across Romania, Croatia, Montenegro, Serbia and Italy. The orders are for Beam Europe’s infrastructure and smart city technology solutions, along with a new order for the Company’s power electronics products in the Italian market. The $1.7 million in single-week orders is approximately double the strongest single week’s...